NewEdge Advisors’s Strata Critical Medical Inc SRTA Stock Holding History

NewEdge Advisors’s Portfolio SRTA Stock Details SRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-58,204	Closed	-$247K	–	3977
2024 Q4	$247K	Buy	58,204 +11,521	+25%	+$43.9K	﹤0.01%	1979
2024 Q3	$137K	Buy	+46,683	New	+$149K	﹤0.01%	2095
2023 Q1	–	Sell	-5,225	Closed	-$16.3K	–	3499
2022 Q4	$16.3K	Buy	+5,225	New	+$22.3K	﹤0.01%	2199
2021 Q3	–	Sell	-15,830	Closed	-$166K	–	1140
2021 Q2	$166K	Buy	15,830 +360	+2%	+$3.55K	﹤0.01%	1068
2021 Q1	$159K	Buy	+15,470	New	+$215K	﹤0.01%	961

Other funds holding SRTA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NewEdge Advisors's SRTA Position: Q1 2025 in Review

NewEdge Advisors sold out of Strata Critical Medical Inc (SRTA) in Q1 2025, closing a stake of 58,204 shares — an estimated $247K sold.

NewEdge Advisors first reported a position in SRTA in Q1 2021 and held it in 5 quarters. The position peaked at $247K in Q4 2024. 118 funds tracked by Wall St. Rank hold SRTA as of Q1 2025.

NewEdge Advisors reported no remaining Strata Critical Medical Inc position as of Q1 2025 after selling out during the quarter.
NewEdge Advisors sold 58,204 Strata Critical Medical Inc shares in Q1 2025, an estimated $247K.
NewEdge Advisors first reported a position in Strata Critical Medical Inc in Q1 2021 and held it in 5 quarters.
NewEdge Advisors's Strata Critical Medical Inc position peaked at $247K in Q4 2024.
118 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2025.

Based on NewEdge Advisors's 13F filing for Q1 2025, filed 15 May 2025.